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Abstract
Background: With cancer being one of the major causes of death around the world, studies are ongoing to find
new chemotherapeutic leads. There are common mechanisms for colorectal cancer (CRC) formation. Several are
connected with oxidative stress-induced cell apoptosis and others are related to imbalanced homeostasis or intake
of drugs/toxins. Plants that have been used for decades in folk and traditional medicine have been accepted as one
of the commonest sources of discovered natural agents of cancer chemotherapy and chemoprevention. The aim
was to study the antioxidant and chemopreventive effects of Strobilanthes crispus on colorectal cancer formation.
Methods: Five groups of rats were injected subcutaneously with AOM, 15 mg/kg body weight, each once weekly
for 2 weeks. The cancer group was continued on 10 % Tween-20 feeding for 8 weeks. The standard drug group
was continued on 35 mg/kg 5-fluorouracil intraperitoneal injection twice a week for 8 weeks, and the experimental
groups were continued on 250 and 500 mg/kg S. crispus extract oral feeding for 8 weeks, respectively. The normal
group was injected subcutaneously with normal saline once a week for 2 weeks, followed by oral administration of
10 % Tween-20 for 8 weeks. All the rats were sacrificed after 10 weeks. The colons were evaluated grossly and
histopathologically for aberrant crypt foci (ACF). Gene expression was performed for Bax, Bcl2, Defa24, Slc24a3, and
APC genes by real-time PCR. S. crispus and its fractions were evaluated for their chemopreventive effects against
human colorectal adenocarcinoma cell line HT29 and cytotoxicity for normal human colon epithelial cell line CCD
841, and the active fraction was assessed for its components.
Results: We observed significant decrease in total colonic ACF formation, malonaldehyde (MDA) and lactate
dehydrogenase (LDH), increase in superoxide dismutase (SOD), up-regulation of APC, Bax and Slc24a3, and
down-regulation of Defa24 and Bcl-2 in rats treated with Strobilanthes crispus.
Conclusion: Our results support the in vivo protection of S. crispus against CRC formation (azoxymethane-induced
aberrant crypt foci) and suggest that the mechanism is highly specific to protect from oxidative insults and the
following apoptotic cascade.
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Background
It is without doubt that the imbalance between the pro-
duction of excess free radicals and the ability of the cell
to neutralize their proximate environment results in ser-
ious consequences such as damage of cell membrane,
disruption of the cytoskeleton proteins harmony and
deformability of the RNA and DNA components. The
gastrointestinal tract is a very sophisticated and compli-
cated organ, characterized by a high metabolic rate,
enteric nervous plexus with numerous feedback loops,
intermingling connections of various enzymes and hor-
mones, and enormous turn-over of metabolites and
toxins. Thus the gastrointestinal tract is highly suscep-
tible to oxidative radicals and accordingly the incidence
of mutations and genetic alterations [1]. The colorectal
segment of the gastrointestinal tract is particularly vul-
nerable due to both the biological function and distal
position. Hence, it is not surprising if colorectal cancer
(CRC) accounts for 13 % of all cancers worldwide and
considered as one of the world’s most common neo-
plasms [2]. Aberrant crypt foci (ACF) are one of the
earliest neoplastic lesions of CRC and an evidential land-
mark during the early stage of tumour formation [3, 4].
Azoxymethane (AOM) induction has been proven to
alter the metabolic balance of the intestinal epithelial
layer, producing hydrogen peroxidase that in turn leads
to thiobarbituric acid-reactive substances (TBARS) re-
lease and formation of free radicals [5]. Previous litera-
ture had documented the different aspects of oxidative
damage attributed also to the up- and down-regulation
of vital genes [6]. Adenomatous polyposis coli (APC), the
pro-apoptotic Bcl-associated X (Bax) and anti-apoptotic B
cell leukemia 2 (Bcl-2) genes are among the altered genes
reported in CRC caused by oxidative stress [7]. Defensin,
alpha, 24 (Defa24) and solute carrier family 26, member 3
(Slc26a3) are newly defined genes that have variant ex-
pression in colon tissues of AOM induced CRC [8]. The
accumulating data support the notion of the role of oxida-
tive stress as a key player in the pathology of cancer [9].
The mechanisms underlying the pathogenesis involve the
rate of cell proliferation versus cell death and accordingly
CRC development and progression [10]. The apoptotic
pathways were also assumed to be consequent to the
oxidative cascade. Apoptosis is a progressive cell loss
with two possible pathways, i.e. intrinsic and extrinsic
[11]. Under pathological conditions, nitric oxide and
related free radicals are thought to play an important
role in initiating both pathways. The excessive prolif-
eration, accumulation of abnormal cells/foci and the
defect of the apoptosis contributed to the conse-
quences of eventual cancer formation. Cascade of ir-
reversible processes attributes to profound structural
and functional disruption leading to a second wave of
gene mutation [12].
The same biological events can be mimicked in vivo
and indirectly monitored in vitro to screen the protective
effects of new chemotherapeutic agents. One of the oldest
and well-known chemotherapeutic drugs, 5-fluorouracil
(FU), is an anti-tumour agent broadly used in the manage-
ment of compact tumours. FU inhibits thymidylate syn-
thase (TS) and is incorporated into the RNA and DNA.
However, FU has many side-effects and is cytotoxic to
normal cells [13]. In this study we applied in vitro and in
vivo strategy to study the chemopreventive effect of Stro-
bilanthes crispus. Biological methods and genetic analysis
were used to investigate the effects of S. crispus on AOM-
induced ACF in rats and evaluate the gene expression in
colon tissue. Traditionally, S. crispus is widely used as a
laxative and to treat gastrointestinal tract disorders [14].
Its extracts has shown effectiveness against the hepatocar-
cinogenesis process [15]. It has been reported to protect
the cell against oxidative insults [16] and possess antipro-
liferative [17], anticancer [18], gastroprotective [19],
wound healing [20] and antimicrobial [21] properties. Sev-
eral co-researchers have used traditional medicinal plants
for the treatment of various elements including colon can-
cer [22]. The present work on S. crispus has revealed a
potent protective effect against CRC formation in two-
dimensional (in vitro) and three-dimensional (in vivo)
horizons. The study was extended however to cover a
broader range of extract fractions with biological exam-
ination and profiling in order to find new bioactive
compounds that demonstrate an antioxidant and anti-
proliferative biological action to develop anti-cancer
drugs. This work is an extension of our continuous
interest in isolation and identification of potent com-
pounds from natural products [23, 24] and the goal was
to test whether S. crispus can exhibit chemopreventive ef-
fect on colon cancer development in vitro and in vivo.
Methods
Preparation of plant extract
S. crispus was obtained from Ethno Resources Sdn. Bhd.,
Selangor, Malaysia, and identified using the voucher
specimens deposited at the Herbarium of Rimba Ilmu,
Institute of Biological Science, University of Malaya,
Kuala Lumpur. Ethanol at 95 % was used to extract the
plant for 3–4 days before filtration and low-pressure
evaporation. For the animal study, the ethanol crude ex-
tract was dissolved in Tween-20 (10 % w/v).
Experimental animals
Thirty healthy adult Sprague Dawley (SD) male rats
(6–8 weeks old) were obtained from the Experimental
Animal House. Each rat weighed between 150 and
180 g, and was placed individually in separate cages.
The study was carried out in accordance with the approval
of the Ethics Committee for Animal Experimentation,
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Faculty of Medicine, University of Malaya, Kuala Lumpur,
Malaysia [Ethic No. PM/07/05/2012/MMA (b) (R)] and in
agreement with the “Guide for the Care and Use of La-
boratory Animals”, published by the National Academy
of Science [25].
Induction and chemoprevention of colon cancer
in animals
Thirty male SD rats were divided into five groups of six
rats each:
Group 1: (Placebo group) was injected subcutaneously
with 0.9 % sterile normal saline once a week for 2 weeks
and fed daily with 10 % Tween-20 (5 ml/kg) for 8 weeks.
Group 2: (AOM group) was injected subcutaneously
with 15 mg/kg/ml of AOM once a week for 2 weeks and
fed daily with 10 % Tween-20 (5 ml/kg) for 8 weeks.
Group 3: (FU group) was injected subcutaneously with
15 mg/kg/ml of AOM once a week for 2 weeks and
injected intraperitoneally with 35 mg/kg 5-FU as standard
drug twice a week for 8 weeks.
Groups 4 and 5: (S. crispus extract groups) were
injected subcutaneously with 15 mg/kg/ml of AOM once
a week for 2 weeks and orally fed with 250 and 500 mg/
kg (5 ml/kg) S. crispus extract once daily for 8 weeks,
respectively.
The experiment was terminated at the end of the 10
weeks, at which point the rats were anaesthetized with
ketamine (50 mg/kg) and xylazine (5 mg/kg), and
sacrificed.
AOM (Sigma Aldrich, St. Louis, MO, USA) was used
to induce ACF in the rat colon after being dissolved in
sterile 0.9 % normal saline. AOM was injected subcuta-
neously into the animals at a dosage of 15 mg/kg once a
week for 2 weeks [26]. 5-FU (Calbiochem, USA) was
used as a standard drug, used as intraperitoneal injection
into the rats at a dosage of 35 mg/kg body weight twice
a week for 8 weeks [27]. In our study, this particular
dose was chosen based on IC50 values obtained from
MTT tests. We used this concentration in the biological
assays as it is in correspondence to the IC50 value for
48 h of treatment as previously described.
Tissue collection
The colons were dissected, and slit open lengthwise
from the anus to the rectum to evaluate the presence of
ACF. Half of the colon tissue was fixed in 10 % phos-
phate buffered formalin, while the other half was placed
in RNA solution (Ambion, Austin, Texas, USA) for fur-
ther use [28]. For gene expression analysis, we selected
Bax, Bcl-2, Defa24, Slc24a3, and APC.
Gross quantification of colon mucosal ACF
Topographic analysis of the colonic mucosa was per-
formed according to a published protocol [29] with
slight modification. The colons were stained with 0.2 %
methylene blue solution for 10 min and the total ACF
number was determined then the multiplicity variables
were used to quantify the aberrant crypts. The aberrant
crypts were distinguished from the normal tissue by
their increase in size, height, and discernible pericryptal
zone. Aberrant crypt multiplicity was determined as the
number of crypts in each focus (2 cm sections) and justi-
fied by the presence of four or more ACF.
Histopathological examination
The colon was fixed for 24 h in 10 % buffered formalin
solution for histological study. Under light microscopy, a
scalpel blade was used to excise the ACF of interest and
the surrounding normal crypts. A 2 × 2 mm dissected
tissue was then sectioned (5 μm thickness), embedded
and stained with haematoxylin and eosin (H & E).
Estimation of antioxidant activity in colon tissue
homogenate
Colon homogenates (10 % w/v) were prepared in cold
50 mM potassium phosphate buffer saline (PBS), pH 7.4.
The cell debris was removed by centrifugation and the
supernatant was used for the estimation of in vivo anti-
oxidants using commercially available kits i.e. malondial-
dehyde (MDA) that indicates the level of thiobarbituric
acid-reactive substances (TBARS; cat. # 10009055), and
superoxide dismutase (SOD; cat. # 706002; Cayman
Chemical Company, USA). All assays were performed ac-
cording to the instruction manual of the manufacturer.
Lactate dehydrogenase (LDH) determination
For LDH assessment, the blood samples were collected
and separated for serum after complete clotting. The
serum was assayed spectrophotometrically.
Gene expression
RNA isolation and purification
The total RNA was extracted from 30 mg colon tissue in
a highly denaturing guanidine-isothiocyanate-containing
buffer using genomic DNA Eliminator columns com-
bined with an RNeasy Plus Mini Kit (QIAGEN, Hilden,
Germany). The total RNA concentration and quality
were evaluated by determining the 260/280 absorbance
ratio using a NanoDrop ND-2000 spectrophotometer
(Thermo Fisher Scientific, Wilmington, DE, USA). The
RNA samples were subjected to agarose gel electro-
phoresis (Additional file 1: Figure S1). The gel was
examined after 30 min at 95 V under UV light to
observe the 18S and 28S ribosomal RNA bands. The
ratio of 28S RNA to 18S RNA was apparently 2:1.
Al-Henhena et al. BMC Complementary and Alternative Medicine  (2015) 15:419 Page 3 of 11
Reverse transcription and cDNA synthesis
Complementary DNA (cDNA) was produced from 1 μg
RNA of each sample using the ‘High Capacity RNA to
cDNA’ master mix protocol (PN 4375575, Applied Bio-
system, Foster City, CA, USA). The RNA was reverse
transcribed to cDNA according to the manufacturer’s
protocol instructions by adjusting RNA to 1 μg/20 μl
with nuclease-free water and 4 μl RT (reverse transcrip-
tion). The samples were loaded into a thermal cycler
(Major Science, CA, USA).
Real time PCR normalization and amplification
The inventoried TaqMan gene expression assays were
selected for the detection of rat RNA transcripts (Applied
Biosystems, Foster, CA, USA). Defa24 (Rn02769344_s1),
Slc26a3 (Rn00709709_ml), APC (Rn00560714_m1), Bax
(Rn02532082_g1), and Bcl-2 (Rn99999125_m1) were se-
lected. Hprt1 (Rn01527840_ml) and Tbp (Rn00560865_m1)
were the endogenous control genes used for normalization
in the rat colon tissue samples, following justification by
geNorm and NormFinder. The analysis showed lower vari-
ability (low M value) of Hprt1 and Tbp, which made them
adequate for normalization. The PCR efficiency (E) for each
gene and correlation coefficient (R2) was determined based
on the slope of the standard curves generated using serial
dilutions of the normal sample of 5-fold cDNA starting
with 10 ng/μl. The efficiency was calculated and the ac-
cepted value was defined as being between 90 and 110 %.
qRT-PCR was performed in triplicate in a total volume of
10 μl containing 5 μl of TaqMan fast advanced master mix,
0.5 μl TaqMan gene expression assay, 1 μl cDNA template,
and 3.5 μl of nuclease free water. The average of the sample
triplicate measurements was obtained for the threshold
cycle (Ct) value. The comparative Ct (2-ΔΔCT) method
was used to compare the gene expression of the targets.
The relative gene expression was quantified as 2-ΔΔCT,
where ΔΔCT= (ΔCT of treated sample RNA) – (ΔCT of
untreated control or normal control RNA), and ΔCT= (CT
target RNA) – (CT reference or endogenous RNA). The re-
sults were normalized to the reference genes and log2 to
positive control [30, 31].
Crude extract fractionation
Firstly, column chromatography was performed to frac-
tionate the plant extract in which a 2.0 × 50 cm glass cy-
linder column with packed silica gel 60 (0.063–0.200 mm,
70–230 mesh; Merck, Germany) was used according to a
previously described method [32]. Different eluting sol-
vents (hexane, ethyl acetate, methanol, acetone, aceto-
nitrile, and water) were passed through the mixture of 1 g
of plant extract/5 ml methanol to extract the fractions.
The resulting fractions were collected, and an EYELA-L1
pump (Tokyo Rikakikai CO., Ltd., Tokyo, Japan) was used
to ensure proper elution [28].
Secondly, thin layer chromatography (TLC) was per-
formed, using aluminum foil pre-coated with silica 60 F254
plate (20 × 20 cm width and 0.2 cm thickness; Merck,
Darmstadt, Germany). The TLC analysis was performed by
using a mixture of ethyl acetate and ethanol and similar
collected fractions were combined together resulting in six
main fractions, denoted as STF1, STF2, STF3, STF4, STF5,
and STF6.
Cell culture
The human epithelial colon cell line CCD 841 (ATCC®
CRL-1790™) and colorectal adenocarcinoma cell line
HT29 (ATCC® HTB-38™) was a gift from Department of
Molecular Medicine, Faculty of Medicine, University of
Malaya. They were grown in RPMI 1640 medium that
was supplemented with 10 % (v/v) fetal bovine serum
(FBS) (J R Scientific, Inc, USA), 1 % antibiotic solution
(penicillin and streptomycin) (Sigma Aldrich, UK) and
incubated at 37 oC in a humidified atmosphere of 5 %
CO2 in air [33]. The plant extracts and its fractions were
prepared by dissolving in dimethyl sulfoxide (DMSO,
Fisher Scientific, UK) at a concentration of 0.01 g/ml,
and were serially diluted to 0.1–1000 μg/ml. The ef-
fect of the plant extract and its fractions on the cells
were studied.
Testing the chemopreventive effects of plant extract
fractions
The human epithelial colon cell line CCD 841 and colo-
rectal adenocarcinoma cell line HT29 were seeded in
96-well plates at a density of 5 × 105 viable cells/well and
incubated for 24 h to allow cell adherence, then treated
with plant extract and its fractions for 48 h. Subsequently,
10 μl MTT (5 gm/ml PBS) was added to each well and the
cells were re-incubated for 4 h. The medium containing
MTT was removed and 100 μl DMSO was added. Cell via-
bility was determined spectrophotometrically at 595 nm.
The fractions which showed positive results were further
tested and identified by high performance liquid chroma-
tography (HPLC) and liquid chromatography-mass spec-
trometry (LC/MS) to determine the cytotoxicity effects.
Separation was achieved by using a Zorbax SB-C18 col-
umn (0.5 × 150 mm, 5 μm; part no: 5064-8256; Agilent,
Vivantis company, USA) and the identification of bioactive
compounds was detected using Agilent 6520 Accurate-
Mass quadruple time-of-flight (Q-TOF) MS system via
dual electrospray ionization.
Statistical analysis
Values were expressed as mean ± SEM. The variation be-
tween groups was estimated by the one-way ANOVA
followed by Tukey’s post-hoc test using SPSS version 20
(SPSS Inc. Chicago, IL, USA). The real-time PCR data of
gene expression were analysed using the GenEx Standard
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program version 6 (GenEx software, MultiD Analyses,
Sweden). T-test was used to examine the differences be-
tween groups for all genes. P value of <0.05 was considered
statistically significant. LC/MS data was processed by using
the Agilent Mass Hunter Qualitative Analysis B.04.00.
Results
S. crispus extract inhibits formation of ACF
The occurrence and multiplicity of ACF in the colon
were observed. The total number of ACF as well as the
number of crypts per focus were counted. Multiple crypt
clusters (more than four crypts/focus) of aberrant crypts
per focus were also reported (Table 1). Rats treated with
AOM and fed with either 250 or 500 mg/kg of the S.
crispus extract showed a significantly lower number of
total ACF/colon compared with the AOM-treated rats.
The incidence of multiple aberrant crypts/focus was also
significantly suppressed in rats fed with S. crispus extract
as compared with the AOM-treated group. The inhib-
ition of ACF formation as a marker for tumour initiation
was recorded as 70.6–71.3 % in the S. crispus treated
groups compared to 72.6 % in the fluorouracil-treated
group when compared with the AOM group. The occur-
rence and multiplicity decreased dramatically in the S.
crispus treated groups compared to both the positive
and negative controls (Fig. 1-1).
Histological analysis
The large number of ACF in AOM rats was accompanied
by enormous cellular changes. The stained crypts exhib-
ited atypical nuclear organization, longer and larger muco-
sal lining, marked condensation of the nuclear materials
and narrower lumen compared to the surrounding normal
crypts. Moreover, the individual cells had distinctive elon-
gated and stratified nuclei, loss of polarity, increase in mi-
toses, and lack of goblet cells (Fig. 1-2). Histopathological
examination revealed the presence of proliferating muco-
sal glands with ACF characterized by elongated stratified
nuclei and the depletion of mucin in the colonic tissue
sections of AOM induced rats compared to the normal
and plant treated rats.
Effects of S. crispus on serum LDH and tissue MDA and
SOD of colon homogenate
The group treated with AOM showed a high level of
MDA and increased lipid peroxidation while it was
markedly decreased in both S. crispus and FU treated
groups. The reverse was seen with SOD, where elevated
activity was observed with S. crispus but not in FU
treated groups compared to the AOM group. S. crispus
and FU treated groups showed significantly lower LDH
activity compared to the AOM group (p < 0.01; Table 2).
RT-PCR measurement
The endogenous genes Hprt1 and Tbp were the en-
dogenous control genes used for the normalization of
the target gene expression (Defa24, Slc26a3, APC, Bax
and Bcl2). The PCR efficiency (E) for each gene, includ-
ing the endogenous control genes, was determined based
on the slope of the standard curves which was between
94 and 156 %. The CT values were normalized to refer-
ence genes Hprt1 and Tbp at slope between 3.2 and 3.5
and analysed by GenEx software. The analysis showed
significant differences between the groups for all the tar-
get genes. The APC expression was up-regulated in the
S. crispus groups with respect to the AOM group (Fig. 2).
The expression of Slc6a3 gene was significantly up-
regulated by 3.957-fold and 5.373-fold, while Defa24 was
down-regulated by 1.897-fold and 1.456-fold in the low-
and high-dose S. crispus groups, respectively, as com-
pared to the AOM group (Table 3, Fig. 2). Defa24 and
Bcl2 in turn were significantly up-regulated in the AOM
group with respect to the placebo group, and Slc26a3
was significantly down-regulated in the AOM group
with respect to the placebo group. Bax was expressed in
higher different ratios but Bcl2 was expressed at a lower
level in the extract groups with respect to the AOM
group.
Biological activity of the plant fractions and profiling of
active compounds
The fractions were assessed in vitro for their chemopre-
ventive effects against human colorectal adenocarcinoma
cell line HT29 and cytotoxicity for human colon epithelial
cell line CCD 841. The crude extract that was assessed
Table 1 Effects of S. crispus extracts on the number of crypts per focus on AOM-induced ACF in rat colons
Group Number of foci ACF
1 crypt 2 crypts 3 crypts 4 crypts >5 crypts Total Inhibition %
Cancer control group (AOM) 26 ± 7.15 36 ± 8.4 31 ± 4.4 25 ± 1.4 32 ± 7.3 150 ± 21.0 0
AOM + 5-FU 10 ± 2.1** 9 ± 2.3** 9 ± 2.6** 5 ± 1.5** 8 ± 2.6** 41 ± 9.6** 72.6 %
AOM+ S. crispus (250 mg/kg) 4 ± 1.4** 11 ± 2.3** 13 ± 0.5** 8 ± 2.5** 8 ± 2.4** 44 ± 4.6** 70.6 %
AOM+ S. crispus (500 mg/kg) 8 ± 0.5** 10 ± 2.7** 11 ± 2.1** 8 ± 1.2** 6 ± 1.2** 43 ± 2** 71.3 %
All values are expressed as mean ± SEM. **Significant difference at p < 0.01 (ANOVA, Tukey’s post hoc). 5-FU 5-Fluorouracil, ACF aberrant crypt foci,
AOM azoxymethane
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firstly against HT29 AND CCD481 (Fig. 3) was separated
by column chromatography into six fractions (STF1-
STF6) according to the differences in molecular size and
polarity. They were investigated for their inhibitory effects
against HT29 and CCD-841. The STF2 and STF3 of S.
crispus at a concentration of 500 μg were the fractions
that exhibited a significant inhibition value, and decreased
the viability for HT29 cancerous colon cells to 27.43 and
9.09 %, respectively, with a corresponding low inhibition
value on CCD-841 colon cells that increased the viability
to 59.66 and 55.53 %, respectively. In contrast, low inhib-
ition effects were observed when fractions STF1, STF4,
STF5 and STF6 of S. crispus were used on the HT29 colon
cancer cells. Fraction SF3 was further tested due to its po-
tent activity by LC/MS and the peaks obtained were iden-
tified (Fig. 4). Caffeic and ferulic acids were isolated in
addition to icariin, and epigallocatechin. Urosolic acid was
also isolated from S. crispus (Figs. 5 and 6, Table 4).
Discussion
S. crispus is a member of the Acanthaceae family. It is na-
tive to subtropical countries such as Madagascar, Indonesia
and Malaysia. It is commonly known as ‘pecah beling’,
‘pokok pecah’, ‘pecah kaca’or ‘jin batu’ in Malaysia. Many
active compounds have been identified from S. crispus with
biological activities and pharmacological functions. In par-
ticular, verbascoside, glycosidic ester of caffeic acid and
seven phenolic acids, namely p-hydroxy benzoic, p-cou-
maric, caffeic, vanilic, gentinic, ferulic, and syryngic acid
have been isolated and identified from the leaves of the
plant [34]. The leaves also contain a high amount of anti-
oxidants, minerals and vitamins C, B1 and B2, as well as
other flavonoid components, such as catechins, caffeine,
and tannin [35]. Other co-researchers have studied the
toxicity of S. crispus in SD rats, with no drug-related haz-
ards, supporting the observations of this study [19, 20].
It was reported that plants belonging to the same family
generally protect cells against oxidative insults and inhibit
ROS formation in cell lines which ultimately cause cell
death [36]. Distinct mechanisms of such protection were
suggested, including increasing intracellular SOD activity.
SOD catalyses the dismutation of superoxide into oxygen
and hydrogen peroxide, thus protecting the cell from
superoxide toxicity and harmful effects [36]. The high
antioxidant activity of SOD has been reported as being an
important factor in the treatment of inflammation of the
colon in colitis and the inhibition of endothelial activation
[37]. In addition, the decrease in the MDA levels leads to
lowering of ROS levels, and redirects the metabolic path-
way in correspondence with the presence of hydroxylated
C3, unsaturated C ring, and hydrophobicity of the extract
Fig. 1 Effect of S. crispus on ACF. 1- Rats colon tissue satin with methylene blue. 2- Cross-section of the rat colon tissues stained with haematoxylin
and eosin. a Normal group with normal, b AOM group, c 5-FU group, d: 250 mg/kg S. crispus group, e: 500 mg/kg S. crispus group. 1-showed the
crypts that were more than five in AOM group foci and less than five in all treated groups foci. Arrows indicated the crypts that were observed with
methylene blue staining. 2-Showed the elongated and slightly stratified nuclei found in AOM group and the depletion of mucin. Treated groups
showed crypts with round nuclei which are normal
Table 2 Effect of S. crispus on SOD and LDH activities and level
of MDA in AOM induced rats
Groups SOD (U/mL) MDA (μM) LDH (U/L)
Normal 6.17 ± 1.17 3.94 ± 0.27 1373.67 ± 137.29
AOM 8.16 ± 1.82 9.98 ± 0.78 1823.50 ± 97.96
FU 3.99 ± 1.12 3.60 ± 0.12*** 776.33 ± 47.32**
S. crispus 250 mg/kg 10.98 ± 0.34* 4.34 ± 0.67*** 729.17 ± 85.94**
S. crispus 500 mg/kg 11.21 ± 0.63* 3.21 ± 0.46*** 779.67 ± 121.08**
All values are expressed as mean ± SEM. Significant difference at *p < 0.01,
**p < 0.001, ***p < 0.0001 vs AOM group (ANOVA, Tukey’s). FU Fluorouracil,
AOM azoxymethane, LDH lactate dehydrogenase, SOD superoxide
dismutase, MDA malondialdehyde
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[17]. In this study, SOD activity was significantly elevated
in S. crispus treated rats compared to untreated controls,
underlining the antioxidant property of this plant.
We investigated the protective mechanisms of S. cris-
pus ethanolic extracts on the morphology of intestinal
crypts against carcinogenic changes induced by AOM. S.
crispus ethanolic extracts rescued the architecture of the
epithelial cells from damage, as seen by the minimum
condensation of nuclear and cytoplasmic vacuoles, at-
tenuation of early apoptosis, no decrease in the luminal
space, and prevention of major changes in size and
shape. S. crispus ethanolic extracts also counteracted the
accumulation of ROS particles and thereafter overex-
pression of Bax gene, and increased the level of LDH in
the animal serum [38]. In addition, S. crispus ethanolic
extracts reduced the number of ACF in a dose and time
dependent manner. Our results show that the protective
effects of S. crispus ethanolic extracts are mediated, at
least in part, by controlling the apoptotic pathway [39].
The protective effect of plant extract and its active
constituents against cancer formation were examined
genetically by using the real-time PCR method. The
results of the present study showed that down-
regulation of mRNA generated by mutation of the APC
gene induced progression in CRC formation similar to
that reported earlier [40]. Down-regulation of APC was
associated with up-regulation of Bcl-2 and increase in the
mRNA level and thus prevented cells from undergoing
apoptosis. This in turn induced cancer progression in the
early stages of the genetic alteration cascades [41]. The
Bax gene was down-regulated in this study; however, it
was not statistically significant. The alteration of both Bax
and Bcl-2 gene expression was associated with improve-
ment of the pathological state [42]. Consequently, the
results suggested that deregulation of the apoptosis
mechanism may have occurred [43].
Additionally, we investigated the newly-defined genes
Slc26a3c and Defa24 expression in colorectal tissue ho-
mogenates. It was found that Defa24 appeared to be
among the most up-regulated genes associated with
AOM induced CRC, while Slc26a3c was among those
that were down-regulated [8] indicating that the gene
mapping was more stable under S. crispus ethanolic ex-
tract treatment. The other possibility is that S. crispus
Fig. 2 RT-PCR analyses showing changes in genes expression levels, expressed as log fold changes of Slc6a3, Defa24, Apc, Bax, and Bcl2 genes of
AOM and treated groups with S. crispus high and low dose (250 and 500 mg/kg) of plant extracts. Values were expressed as mean ± SEM. *Differences
were significant at the 0.05 level vs. the AOM group
Table 3 Effect of S. crispus crude ethanol extract on gene expression of colon tissues of AOM-induced CRC in rats
Genes Slc26a3 Defa24 APC Bax Bcl2
Animal groups
Calibrator (Normal) 0 0 0 0 0
AOM −4.47 ± 0.43b 9.49 ± 0.48b −1.38 ± 0.31a −1.40 ± 0.21a 1.49 ± 0.21a
S. crispus 250 mg/kg 3.96 ± 0.54ab −1.90 ± 0.60ab 1.528 ± 0.34b 1.66 ± 0.29b 1.17 ± 0.24
S. crispus 500 mg/kg 5.37 ± 0.41ab −1.46 ± 0.70ab 1.52 ± 0.33b 1.71 ± 0.35b 1.26 ± 0.16
The values were expressed as mean ± SEM, representing fold changes of target gene expression. Two-tailed unpaired student’s test was used. aSignificant difference at
the 0.05 level between AOM-induced group and calibrator; bsignificant difference between treated groups and induced (AOM) group
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Fig. 3 Effect of S. crispus on HT29 colon cancer cell line proliferation. Data were expressed as mean ± SEM for triplicates (*indicate the significant
differences compared with control P-value≤ 0.05 *P < 0.01, **P < 0.001, ***P < 0.0001 (ANOVA, Tukey’s)
Fig. 4 The effect of S. crispus fractions STF2 and STF3 on the viability of HT29 and CCD. Data were expressed as the mean ± SEM for triplicates
Fig. 5: Effect of S. crispus fractions (STF2 & STF3) on HT29 colon cancer cell line proliferation. Data were expressed as mean ± SEM for triplicates
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ethanolic extract protected protein conformation from
undergoing a change that may be deleterious, which is
propagated by free radicals at the genetic level.
We investigated the effects of exposure of two cell
lines to the plant extract and its fractions, to determine
the potential protective mechanisms of compounds in
cancer formation. Exposure of HT29 and CCD-841 to plant
extract and fractions induced a concentration-dependent
decrease in cell viability as determined by the MTT assay.
Apoptosis of HT29 and CCD-841 was indicated through
the expression of apoptotic and antiapoptotic markers of
Bax and Bcl-2 genes. S. crispus fractions STF2 and STF3
displayed significant effect on HT29 cell death at 27.43 and
9.09 %, respectively. These two fractions were also effective
on CCD-841 colon cells with viability of 59.66 and 55.53 %,
respectively. On the other hand, the other four S. crispus
fractions STF1, STF4, STF5 and STF6 were less effective on
both cell lines. The major compounds identified were
icariin and epigallocatechin, belonging to the flavonoid fam-
ily of structures. These findings are in agreement with the
literature describing S. crispus chemical composition [35].
Flavonoids have been suggested to have an effective role in
the inhibition of carcinogenesis. Previous studies have re-
ported the potency of flavonoids as antioxidants and their
chemopreventive activity against many forms of cancer.
Most of these studies have been carried out by using
natural sources of flavonoids to test their antiproliferative
activity on animal models [44]. Furthermore, some studies
have reported the anticancer effect through in vitro studies
[45]. In this study, different constituents of S. crispus
Fig. 5 Chromatogram of STF3 of S. crispus negative mode (in 100 % methanol + 0.1 formic acid. The peaks numbers 1, 2, 3, 4, 7 represent the
different RT and m/z of octadecadienoic acid, and peaks 5 and 6 represent urosolic acid and cis-12-oleic acid, respectively
Fig. 6 Chromatogram of SF3 of S. crispus positive mode (in 100 % methanol + 0.1 formic acid. The peaks numbers 8–14 represent ferulic acid,
epigallocatechin gallate, lutein, icariin, triacylglycerol, caffeic acid and kaempferol, respectively
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showed different effects on the cells. The total flavonoid
components of S. crispus (a mixture of flavonoids, caffeic,
ferulic acids and urosolic acid) protected colorectal cells
from oxidative damage and apoptosis. Flavonoids and other
active compounds did show a synergic effect in the in vivo
version of the experimental set. S. crispus as a whole and its
components showed significant decrease in total colonic
ACF formation, increase in SOD activity, significant de-
crease in LDH activity and MDA level, up-regulation of
Apc and Bax, up-regulation of Slc24a3, and down-
regulation of both Defa24 and Bcl-2. Taken together, S. cris-
pus and its composition of polyphenolic compounds dem-
onstrated chemopreventive properties against CRC both
in vitro and in vivo.
Conclusion
Our study demonstrated the cytoprotective activity of S.
crispus against zoxymethane-induced aberrant crypt foci.
The in vitro and in vivo results supported the biological
effect for a wide range of S. crispus extract fractions and
extended to elucidate the underlying mechanism of ac-
tion. The genetic profiling pinpointedthat the potent
antioxidant effect was due to regulation of the genes in-
volved in the apoptotic cascadederived from azoxy-
methane oxidative insult.
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